Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 2 | -$0.09 | -$0.05 | -$0.08 |
Q2 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q4 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
Precigen, Inc. last posted its earnings results on Wednesday, March 19th, 2025. The company reported $-0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.02. The company had revenue of 1.19 M for the quarter and had revenue of 3.93 M for the year. Precigen, Inc. has generated $0 earnings per share over the last year ($-0.46 diluted earnings per share) and currently has a price-to-earnings ratio of -3.24. Precigen, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
04/28/2025 | Q4 2024 | N/A | -$0.07 | N/A | $3.03 M | $1.19 M |
11/14/2024 | Q3 2024 | -$0.08 | -$0.09 | -0.01 | $931.40 K | $953.00 K |
08/14/2024 | Q2 2024 | -$0.09 | -$0.23 | -0.14 | $1.29 M | $717.00 K |
03/29/2024 | Q1 2024 | N/A | -$0.10 | N/A | $1.48 M | $1.07 M |
12/29/2023 | Q4 2023 | N/A | -$0.13 | N/A | $2.13 M | $1.23 M |
11/09/2023 | Q3 2023 | -$0.08 | -$0.08 | 0 | $1.60 M | $1.38 M |
08/09/2023 | Q2 2023 | -$0.10 | -$0.08 | 0.02 | $2.15 M | $1.77 M |
05/10/2023 | Q1 2023 | -$0.08 | -$0.10 | -0.02 | $2.23 M | $1.85 M |
03/06/2023 | Q4 2022 | -$0.10 | -$0.11 | -0.01 | $6.21 M | $1.76 M |
11/09/2022 | Q3 2022 | $0.10 | $0.44 | 0.34 | $2.72 M | $16.72 M |
08/08/2022 | Q2 2022 | -$0.16 | -$0.13 | 0.03 | $22.54 M | $2.91 M |
05/09/2022 | Q1 2022 | -$0.14 | -$0.10 | 0.04 | $28.33 M | $32.02 M |
03/01/2022 | Q4 2021 | -$0.14 | -$0.13 | 0.01 | $24.30 M | $24.22 M |
11/08/2021 | Q3 2021 | -$0.14 | -$0.15 | -0.01 | $20.94 M | $21.56 M |
08/09/2021 | Q2 2021 | -$0.12 | -$0.10 | 0.02 | $21.06 M | $33.58 M |
05/10/2021 | Q1 2021 | -$0.16 | -$0.09 | 0.07 | $24.00 M | $24.51 M |
03/01/2021 | Q4 2020 | -$0.16 | -$0.23 | -0.07 | $21.20 M | $19.33 M |
11/09/2020 | Q3 2020 | -$0.11 | -$0.18 | -0.07 | $17.70 M | $23.58 M |
08/10/2020 | Q2 2020 | -$0.07 | -$0.26 | -0.19 | $16.14 M | $30.42 M |
05/11/2020 | Q1 2020 | N/A | -$0.35 | N/A | $10.50 M | $29.84 M |
Precigen, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based offlast year's report dates.
In the previous quarter, Precigen, Inc. (:PGEN) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.02.
The conference call for Precigen, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Precigen, Inc.'s latest earnings report can be read online.
Precigen, Inc. (:PGEN) has a recorded annual revenue of $3.93 M.
Precigen, Inc. (:PGEN) has a recorded net income of $-126,235,000.Precigen, Inc. has generated $-0.46 earnings per share over the last four quarters.
Precigen, Inc. (:PGEN) has a price-to-earnings ratio of -3.24 and price/earnings-to-growth ratio is -0.29.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED